Panel discussion 'Right to Try'
13:30 - 14:00 | Rotterdam Hall
Societal changes and digital innovation have led to growing patient empowerment in healthcare. In the U.S. ‘Right-to-try’ laws have even been created to give terminally ill patients access to novel drugs that are not yet approved by the FDA, but are likely to save their lives.
What are the pros and cons of giving patients early access to experimental drugs? Should patients have extra options beyond what is currently available via compassionate use?
During this panel session we will discuss this topic with stakeholders from different perspectives.
Maurits van Selms
ALS patient & ACTA
Ton de Boer
Medicine Evaluation Board
Ingmar de Gooijer
After six succesful editions, Innovation for Health will be organised for the seventh year in a row on Thursday 13 February 2020!
We will open registration for this new edition in May 2019. From that moment on you can benefit from attractive early-bird rates. When you are interested in participation as e.g. sponsor, exhibitor or speaker, you can contact us directly via phone or e-mail.
The aftermovie of Innovation for Health 2019 is online now, including highlights of the programme and exhibition.
Watch the aftermovie and experience Innovation for Health 2019 in only 2 minutes!
Looking forward welcoming you to the next edition of Innovation for Health in 2020! (date will be announced soon)
Watch the aftermovie
Did you enjoy Innovation for Health & Global Investor Forum 2019?
Take a look at our photo impression and you will experience the event of 14 February all over again!
Go to Photo Impression
© 2019 Innovation for Health